LNP-CDP mRNA therapy (Repair Biotechnologies)

N/A

Report date: 2025/01/26 15:48:09
NME

Base Information

Drug NameLNP-CDP mRNA therapy (Repair Biotechnologies)
Drug Alias Nameliver-targeted LNP-encapsulated ApoE mRNA therapy (Repair Biotechnologies)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionApolipoprotein E agonists
TargetsApolipoprotein E
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRepair Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesRepair Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A